Just The Tonix: New York Biotech Has Breakthrough Drug For PTSD

Tonix Pharmaceuticals has won a breakthrough therapy designation this month for its post-traumatic stress disorder drug – the most advanced product in development specifically for the condition and potentially the first ever to market targeting PTSD as its lead indication.

More from Strategy

More from Business